Surveyed Experts Indicate That The Combination Of Sutent And Taxol Has Advantages Ove

[News]

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed oncologists identify a therapy's effect on overall survival as the attribute that most influences their prescribing decisions in metastatic triple-negative breast cancer.

More... (http://www.medicalnewstoday.com/articles/147174.php)